Supernus Pharmaceuticals Inc (SUPN)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Jack A. Khattar
Employees:
590
1550 E GUDE DR, ROCKVILLE, MD 20850
301-838-2500

Supernus Pharmaceuticals, Inc. focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products include Trokendi XR, an extended release topiramate product indicated for the. treatment of epilepsy, as well as for the prophylaxis of migraine headache. The company markets and sells its products through pharmaceutical wholesalers, specialty pharmacies, and distributors.

Data derived from most recent annual or quarterly report
Market Cap 1.892 Billion Shares Outstanding54.058 Million Avg 30-day Volume 532.879 Thousand
P/E Ratio29.6691 Dividend Yield0.0 EPS0.03
Price to Revenue2.7339 Debt to Equity0.5704 EBITDA123.689 Million
Price to Book Value1.9428 Operating Margin14.838299999999998 Enterprise Value1.592 Billion
Current Ratio1.908 EPS Growth-0.585 Quick Ratio1.549
1 Yr BETA 0.6972 52-week High/Low 42.09 / 24.95 Profit Margin9.2146
Operating Cash Flow Growth-8.1446 Altman Z-Score2.0934 Free Cash Flow to Firm -366.39 Million
Earnings Report2023-05-09
View SEC Filings from SUPN instead.

View recent insider trading info

Supernus Pharmaceuticals Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding SUPN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SUPN

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-03-16 by MOTTOLA FRANK
  • 4: filed on 2023-02-27 by BHATT PADMANABH P.
  • 4: filed on 2023-02-27 by RUBIN JONATHAN
  • 4: filed on 2023-02-27 by DEC TIMOTHY C
  • 4: filed on 2023-02-27 by MARTIN TAMI TILLOTSON
  • 4: filed on 2023-02-27 by KHATTAR JACK A.
  • 4: filed on 2023-02-27 by HUDSON FREDERICK M.
  • 4: filed on 2023-02-27 by NEWHALL CHARLES W III
  • 4: filed on 2023-02-27 by BARLOW CARROLEE
  • 4: filed on 2023-02-27 by GEMAYEL GEORGES

    • Events (8k)

  • 8-K: filed on 2023-03-01:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-28:
    Item 2.02: Results of Operations and Financial Condition
  • 8-K: filed on 2022-11-08:
    Item 2.02: Results of Operations and Financial Condition
  • 8-K: filed on 2022-10-25:
    Item 2.02: Results of Operations and Financial Condition
  • 8-K: filed on 2022-10-11:
    Item 8.01: Other Events
  • 8-K: filed on 2022-08-04:
    Item 2.02: Results of Operations and Financial Condition
  • 8-K: filed on 2022-07-26:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-17:
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-09:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    19.8 Thousand total shares from 5 transactions

    Exercise Derivative Conversion (M)

    29.5 Thousand total shares from 7 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    MOTTOLA FRANK SR VP, QUALITY, GMP OPER. & IT

    • Officer
    		 4,737 2023-03-14 5

    NEWHALL CHARLES W III

    • Director
    		 112,132 2023-02-23 4

    SIEBERT JOHN M

    • Director
    		 84,057 2023-02-23 2

    DEC TIMOTHY C SENIOR VICE-PRESIDENT & CFO

    • Officer
    		 1,341 2023-02-23 3

    GEMAYEL GEORGES

    • Director
    		 13,315 2023-02-23 2

    HUDSON FREDERICK M.

    • Director
    		 34,867 2023-02-23 3

    BHATT PADMANABH P. SR. VP OF IP, CSO

    • Officer
    		 3,247 2023-02-23 8

    MARTIN TAMI TILLOTSON SR. V.P., REGULATORY AFFAIRS

    • Officer
    		 90,323 2023-02-23 6

    KHATTAR JACK A. PRESIDENT, CEO

    • Officer
    • Director
    		 1,851,972 2023-02-23 19

    BARLOW CARROLEE

    • Director
    		 13,315 2023-02-23 2

    RUBIN JONATHAN SVP, CHIEF MEDICAL OFFICER

    • Officer
    		 2,497 2023-02-23 4

    KELLY JAMES PATRICK EXECUTIVE VICE-PRESIDENT & CFO

    • Officer
    		 15,000 2021-02-19 0

    SCHWABE STEFAN K.F. EXECUTIVE VICE PRESIDENT & CMO

    • Officer
    		 2,772 2020-12-21 0

    PATRICK GREGORY S SR. VP CHIEF FINANCIAL OFFICER

    • Officer
    		 44,463 2020-11-09 0

    LENGAUER CHRISTOPH

    • Director
    		 0 2019-04-17 0

    PINSCHEWER DAVID CHIEF SCIENTIFIC OFFICER

    • Officer
    		 0 2019-04-17 0

    MATUSHANSKY IGOR CHIEF MEDICAL OFFICER

    • Officer
    		 0 2019-04-17 0

    VAUGHN VICTOR SR. VP OF SALES & MARKETING

    • Officer
    		 9,344 2018-04-18 0

    NUERGE WILLIAM A.

    • Director
    		 23,750 2017-06-13 0

    BARRETT M JAMES

    • Director
    		 212,710 2016-03-16 0

    BARRIS PETER J

    • 10% Owner
    		 No longer subject to file 2015-11-11 0

    SANDELL SCOTT D

    • 10% Owner
    		 No longer subject to file 2015-11-11 0

    NEW ENTERPRISE ASSOCIATES 11 LP

    • 10% Owner
    		 No longer subject to file 2015-11-11 0

    NEA PARTNERS 11 LP

    • 10% Owner
    		 No longer subject to file 2015-11-11 0

    KOLLURI KRISHNA KITTU

    • 10% Owner
    		 No longer subject to file 2015-11-11 0

    BASKETT FOREST

    • 10% Owner
    		 No longer subject to file 2015-11-11 0

    BRYAN JONES W. VP OF BUSINESS DEVELOPMENT

    • Officer
    		 67,980 2015-03-30 0

    BIGHAM MICHAEL

    • Director
    		 43,722 2013-03-20 0

    ORBIMED ADVISORS LLC

    ISALY SAMUEL D

    ORBIMED CAPITAL GP II LLC

    • 10% Owner
    		 No longer subject to file 2013-02-12 0

    NEW ENTERPRISE ASSOCIATES 11 LP

    NEA PARTNERS 11 LP

    NEA 11 GP, LLC

    BARRIS PETER J

    BASKETT FOREST

    DRANT RYAN D

    KOLLURI KRISHNA KITTU

    KRAMLICH C RICHARD

    PERRY MARK W

    SANDELL SCOTT D

    • 10% Owner
    		 10,641,250 2012-05-04 0

    SHEFFERY MICHAEL B

    • Director
    		 6,099,996 2012-05-04 0

    ABINGWORTH MANAGEMENT LTD

    • 10% Owner
    		 3,600,000 2012-05-04 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    MOTTOLA FRANK - Officer SR VP, QUALITY, GMP OPER. & IT

    		2023-03-16 17:00:55 -0400 2023-03-14 S 4,780 $35.99 d 4,737 direct 1.8609 1.8609 2 0.0 1

    BHATT PADMANABH P. - Officer SR. VP OF IP, CSO

    		2023-02-27 17:04:05 -0500 2023-02-23 A 5,000 a 5,000 direct

    BARLOW CARROLEE - Director

    		2023-02-27 17:01:54 -0500 2023-02-23 A 3,886 a 3,886 direct

    BARLOW CARROLEE - Director

    		2023-02-27 17:01:54 -0500 2023-02-23 A 6,293 a 6,293 direct

    GEMAYEL GEORGES - Director

    		2023-02-27 17:01:31 -0500 2023-02-23 A 3,886 a 3,886 direct

    GEMAYEL GEORGES - Director

    		2023-02-27 17:01:31 -0500 2023-02-23 A 6,293 a 6,293 direct

    MOTTOLA FRANK - Officer SVP, QUALITY, GMP, OPS, IT

    		2023-02-27 17:00:46 -0500 2023-02-23 A 7,500 a 7,500 direct

    MOTTOLA FRANK - Officer SVP, QUALITY, GMP, OPS, IT

    		2023-02-27 17:00:46 -0500 2023-02-23 A 30,000 a 30,000 direct

    BHATT PADMANABH P. - Officer SR. VP OF IP, CSO

    		2023-02-27 17:04:05 -0500 2023-02-23 A 20,000 a 20,000 direct

    RUBIN JONATHAN - Officer SVP, CHIEF MEDICAL OFFICER

    		2023-02-27 17:03:50 -0500 2023-02-23 A 5,000 a 5,000 direct

    RUBIN JONATHAN - Officer SVP, CHIEF MEDICAL OFFICER

    		2023-02-27 17:03:50 -0500 2023-02-23 A 20,000 a 20,000 direct

    KHATTAR JACK A. - Director - Officer PRESIDENT, CEO

    		2023-02-27 17:02:35 -0500 2023-02-23 A 280,000 a 280,000 direct

    HUDSON FREDERICK M. - Director

    		2023-02-27 17:02:29 -0500 2023-02-23 A 6,293 a 6,293 direct

    SIEBERT JOHN M - Director

    		2023-02-27 17:01:09 -0500 2023-02-23 A 6,293 a 6,293 direct

    SIEBERT JOHN M - Director

    		2023-02-27 17:01:09 -0500 2023-02-23 A 3,886 a 3,886 direct

    NEWHALL CHARLES W III - Director

    		2023-02-27 17:02:10 -0500 2023-02-23 A 6,293 a 6,293 direct

    NEWHALL CHARLES W III - Director

    		2023-02-27 17:02:10 -0500 2023-02-23 A 3,886 a 3,886 direct

    MARTIN TAMI TILLOTSON - Officer SR. V.P., REGULATORY AFFAIRS

    		2023-02-27 17:03:01 -0500 2023-02-23 A 20,000 a 20,000 direct

    MARTIN TAMI TILLOTSON - Officer SR. V.P., REGULATORY AFFAIRS

    		2023-02-27 17:03:01 -0500 2023-02-23 A 5,000 a 5,000 direct

    DEC TIMOTHY C - Officer SENIOR VICE-PRESIDENT & CFO

    		2023-02-27 17:03:10 -0500 2023-02-23 A 40,000 a 40,000 direct

    DEC TIMOTHY C - Officer SENIOR VICE-PRESIDENT & CFO

    		2023-02-27 17:03:10 -0500 2023-02-23 A 10,000 a 10,000 direct

    HUDSON FREDERICK M. - Director

    		2023-02-27 17:02:29 -0500 2023-02-23 A 3,886 a 3,886 direct

    NEWHALL CHARLES W III - Director

    		2023-02-24 17:08:11 -0500 2023-02-22 D 3,882 d 0 direct

    MOTTOLA FRANK - Officer SVP, QUALITY, GMP, OPS, IT

    		2023-02-24 17:01:22 -0500 2023-02-22 D 750 d 2,250 direct

    MOTTOLA FRANK - Officer SVP, QUALITY, GMP, OPS, IT

    		2023-02-24 17:01:22 -0500 2023-02-22 A 750 a 9,517 direct -0.9747 1.1064 4.9526 4 -0.9747 2

    BARLOW CARROLEE - Director

    		2023-02-24 17:12:25 -0500 2023-02-22 D 3,882 d 0 direct

    BARLOW CARROLEE - Director

    		2023-02-24 17:12:25 -0500 2023-02-22 A 3,882 a 13,315 direct -0.9747 1.1064 4.9526 4 -0.9747 2

    HUDSON FREDERICK M. - Director

    		2023-02-24 17:11:07 -0500 2023-02-22 D 3,882 d 0 direct

    HUDSON FREDERICK M. - Director

    		2023-02-24 17:11:07 -0500 2023-02-22 A 3,882 a 34,867 direct -0.9747 1.1064 4.9526 4 -0.9747 2

    GEMAYEL GEORGES - Director

    		2023-02-24 17:14:41 -0500 2023-02-22 D 3,882 d 0 direct

    GEMAYEL GEORGES - Director

    		2023-02-24 17:14:41 -0500 2023-02-22 A 3,882 a 13,315 direct -0.9747 1.1064 4.9526 4 -0.9747 2

    SIEBERT JOHN M - Director

    		2023-02-24 17:16:48 -0500 2023-02-22 D 3,882 d 0 direct

    SIEBERT JOHN M - Director

    		2023-02-24 17:16:48 -0500 2023-02-22 A 3,882 a 84,057 direct -0.9747 1.1064 4.9526 4 -0.9747 2

    NEWHALL CHARLES W III - Director

    		2023-02-24 17:08:11 -0500 2023-02-22 A 3,882 a 112,132 direct -0.9747 1.1064 4.9526 4 -0.9747 2

    MARTIN TAMI TILLOTSON - Officer SR. V.P., REGULATORY AFFAIRS

    		2023-02-24 17:02:30 -0500 2023-02-22 D 750 d 2,250 direct

    MARTIN TAMI TILLOTSON - Officer SR. V.P., REGULATORY AFFAIRS

    		2023-02-24 17:02:30 -0500 2023-02-22 A 750 a 90,323 direct -0.9747 1.1064 4.9526 4 -0.9747 2

    DEC TIMOTHY C - Officer SENIOR VICE-PRESIDENT & CFO

    		2023-02-24 17:03:42 -0500 2023-02-22 D 500 d 1,500 direct

    DEC TIMOTHY C - Officer SENIOR VICE-PRESIDENT & CFO

    		2023-02-24 17:03:42 -0500 2023-02-22 A 500 a 1,341 direct -0.9747 1.1064 4.9526 4 -0.9747 2

    BHATT PADMANABH P. - Officer SR. VP OF IP, CSO

    		2023-02-24 17:06:01 -0500 2023-02-22 D 750 d 2,250 direct

    BHATT PADMANABH P. - Officer SR. VP OF IP, CSO

    		2023-02-24 17:06:01 -0500 2023-02-22 A 750 a 3,247 direct -0.9747 1.1064 4.9526 4 -0.9747 2

    RUBIN JONATHAN - Officer SVP, CHIEF MEDICAL OFFICER

    		2023-02-24 17:00:52 -0500 2023-02-22 D 750 d 2,250 direct

    RUBIN JONATHAN - Officer SVP, CHIEF MEDICAL OFFICER

    		2023-02-24 17:00:52 -0500 2023-02-22 A 750 a 2,497 direct -0.9747 1.1064 4.9526 4 -0.9747 2

    MARTIN TAMI TILLOTSON - Officer SR. V.P., REGULATORY AFFAIRS

    		2023-02-21 17:01:54 -0500 2023-02-16 M 1,500 d 0 direct

    DEC TIMOTHY C - Officer SENIOR VICE-PRESIDENT & CFO

    		2023-02-21 17:02:33 -0500 2023-02-16 A 1,500 a 1,500 direct

    MARTIN TAMI TILLOTSON - Officer SR. V.P., REGULATORY AFFAIRS

    		2023-02-21 17:01:54 -0500 2023-02-16 M 1,500 a 88,720 direct 0.0778 1.763 1.763 6 -2.5408 5

    RUBIN JONATHAN - Officer SVP, CHIEF MEDICAL OFFICER

    		2023-02-21 17:01:38 -0500 2023-02-16 M 1,500 a 1,500 direct 0.0778 1.763 1.763 6 -2.5408 5

    RUBIN JONATHAN - Officer SVP, CHIEF MEDICAL OFFICER

    		2023-02-21 17:01:38 -0500 2023-02-16 M 1,500 d 0 direct

    MOTTOLA FRANK - Officer SVP, QUALITY, GMP, OPS, IT

    		2023-02-21 17:35:38 -0500 2023-02-16 M 1,500 a 8,944 direct 0.0778 1.763 1.763 6 -2.5408 5

    MOTTOLA FRANK - Officer SVP, QUALITY, GMP, OPS, IT

    		2023-02-21 17:35:38 -0500 2023-02-16 M 1,500 d 0 direct

    KHATTAR JACK A. - Director - Officer PRESIDENT, CEO

    		2023-02-21 17:38:13 -0500 2023-02-16 A 20,000 a 20,000 direct

    MOTTOLA FRANK - Officer SVP, QUALITY, GMP, OPS, IT

    		2023-02-21 17:35:38 -0500 2023-02-16 F 753 $38.74 d 8,191 direct 0.0778 1.763 1.763 6 -2.5408 5

    KHATTAR JACK A. - Director - Officer PRESIDENT, CEO by the kbt trust

    		2023-02-16 17:00:25 -0500 2023-02-15 J 8,750 d 1,038,950 indirect -1.2214 -3.4097 0.0 1 -3.4097 6

    KHATTAR JACK A. - Director - Officer PRESIDENT, CEO

    		2023-02-16 17:00:25 -0500 2023-02-15 J 8,750 a 813,022 direct -1.2214 -3.4097 0.0 1 -3.4097 6

    KHATTAR JACK A. - Director - Officer PRESIDENT, CEO

    		2023-02-06 17:01:04 -0500 2023-02-03 S 200 $42.02 a 804,272 direct yes 0.3933 1.1536 -7.2889 4.4573 17 -8.4164 28

    KHATTAR JACK A. - Director - Officer PRESIDENT, CEO

    		2023-02-06 17:01:04 -0500 2023-02-03 M 330 $9.56 a 804,472 direct yes 0.3933 1.1536 -7.2889 4.4573 17 -8.4164 28

    KHATTAR JACK A. - Director - Officer PRESIDENT, CEO

    		2023-02-06 17:01:04 -0500 2023-02-03 M 330 d 25,037 direct yes

    KHATTAR JACK A. - Director - Officer PRESIDENT, CEO

    		2023-02-06 17:01:04 -0500 2023-02-02 S 13,532 $42.06 d 804,142 direct yes 0.3933 1.1536 -7.2889 4.4573 17 -8.4164 28

    KHATTAR JACK A. - Director - Officer PRESIDENT, CEO

    		2023-02-06 17:01:04 -0500 2023-02-02 M 22,515 $9.56 a 817,674 direct yes 0.3933 1.1536 -7.2889 4.4573 17 -8.4164 28

    KHATTAR JACK A. - Director - Officer PRESIDENT, CEO

    		2023-02-06 17:01:04 -0500 2023-02-02 M 22,515 d 25,367 direct yes

    KHATTAR JACK A. - Director - Officer PRESIDENT, CEO

    		2023-02-03 17:00:49 -0500 2023-02-01 M 498 d 47,882 direct yes

    KHATTAR JACK A. - Director - Officer PRESIDENT, CEO

    		2023-02-03 17:00:49 -0500 2023-02-01 M 498 $9.56 a 795,459 direct yes -6.4049 -3.2147 -9.9387 0.0 1 -14.2822 29

    KHATTAR JACK A. - Director - Officer PRESIDENT, CEO

    		2023-02-03 17:00:49 -0500 2023-02-01 S 300 $42.01 d 795,159 direct yes -6.4049 -3.2147 -9.9387 0.0 1 -14.2822 29

    KHATTAR JACK A. - Director - Officer PRESIDENT, CEO

    		2023-02-02 17:00:40 -0500 2023-01-31 S 976 $42.01 d 794,961 direct yes -2.0668 -7.0656 -14.4917 0.0 1 -16.0538 30

    KHATTAR JACK A. - Director - Officer PRESIDENT, CEO

    		2023-02-02 17:00:40 -0500 2023-01-31 M 1,620 d 48,380 direct yes

    KHATTAR JACK A. - Director - Officer PRESIDENT, CEO

    		2023-02-02 17:00:40 -0500 2023-01-31 M 1,620 $9.56 a 795,937 direct yes -2.0668 -7.0656 -14.4917 0.0 1 -16.0538 30

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    SUPERNUS PHARMACEUTICALS INC SUPN 2023-03-24 17:15:03 UTC 4.57 0.25 2700000
    SUPERNUS PHARMACEUTICALS INC SUPN 2023-03-24 16:45:03 UTC 4.5694 0.2506 2700000
    SUPERNUS PHARMACEUTICALS INC SUPN 2023-03-24 16:15:03 UTC 4.5694 0.2506 2700000
    SUPERNUS PHARMACEUTICALS INC SUPN 2023-03-24 15:45:03 UTC 4.5694 0.2506 2700000
    SUPERNUS PHARMACEUTICALS INC SUPN 2023-03-24 15:15:03 UTC 4.5694 0.2506 2700000
    SUPERNUS PHARMACEUTICALS INC SUPN 2023-03-24 14:45:03 UTC 4.5694 0.2506 2700000
    SUPERNUS PHARMACEUTICALS INC SUPN 2023-03-24 14:15:03 UTC 4.5694 0.2506 2700000
    SUPERNUS PHARMACEUTICALS INC SUPN 2023-03-24 13:45:03 UTC 4.32 0.25 2700000
    SUPERNUS PHARMACEUTICALS INC SUPN 2023-03-24 13:15:04 UTC 4.32 0.25 2700000
    SUPERNUS PHARMACEUTICALS INC SUPN 2023-03-24 12:45:03 UTC 4.32 0.25 2700000
    SUPERNUS PHARMACEUTICALS INC SUPN 2023-03-23 22:15:04 UTC 4.32 0.25 2900000
    SUPERNUS PHARMACEUTICALS INC SUPN 2023-03-23 21:45:04 UTC 4.32 0.25 2900000
    SUPERNUS PHARMACEUTICALS INC SUPN 2023-03-23 21:15:04 UTC 4.32 0.25 2900000
    SUPERNUS PHARMACEUTICALS INC SUPN 2023-03-23 20:45:03 UTC 4.32 0.25 2900000
    SUPERNUS PHARMACEUTICALS INC SUPN 2023-03-23 20:15:03 UTC 4.32 0.25 2900000
    SUPERNUS PHARMACEUTICALS INC SUPN 2023-03-23 19:45:03 UTC 4.32 0.25 2900000
    SUPERNUS PHARMACEUTICALS INC SUPN 2023-03-23 19:15:03 UTC 4.32 0.25 2900000
    SUPERNUS PHARMACEUTICALS INC SUPN 2023-03-23 18:45:04 UTC 4.32 0.25 2900000
    SUPERNUS PHARMACEUTICALS INC SUPN 2023-03-23 18:15:03 UTC 4.32 0.25 2900000
    SUPERNUS PHARMACEUTICALS INC SUPN 2023-03-23 17:45:03 UTC 4.32 0.25 2900000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Calamos Investment Trust/IL- Calamos Market Neutral Income Fund SUPN -36000.0 shares, $-1233720.0 2022-10-31 N-PORT

    Congressional Transactions Past 6-Months

    To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***
    Congress Person Party Chamber Filing Filing Date Transaction Date Security Type Owner Transaction Amount
    Hon. Josh Gottheimer democrat House Filing 2023-01-04 2022-12-23 JT SP $1,001-$15,000

    Elevate your investments